Live feed
Filing
SC 13D/A
SC 13D/A0001193125-19-159860·BridgeBio Pharma, Inc.
Schedule 13D ownership disclosure
EIDOS THERAPEUTICS INC
Security class unavailable · CUSIP: 28249H104
Event date: 2019-05-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 64.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-159860
- Form type
- SC 13D/A
- Filer
- BridgeBio Pharma, Inc.
- CIK
- CIK 1743881
- Filed
- May 30, 2019
- Reporting period
- May 24, 2019
- Description
- Schedule 13D beneficial ownership